Regemat 3D bioprinters is a biotechnology company, developing specialised bioprinters for regenerative medicine and tissue engineering.
Engineers design these modular, customisable systems to meet specific research needs, combining 3D bioprinting with proprietary bioreactors to create functional tissues from cell-laden scaffolds.
REGEMAT 3D technology combines custom 3D bioprinters with bioreactors and biomaterials to create functional tissues for regenerative medicine research. Their systems are designed for research centres and hospitals to fabricate cell-free or cell-laden scaffolds that can mature into living tissues through physical stimulation.
Key features include a variety of extrusion methods and personalised software. Interchangeable tools (like heated syringes or UV lights) and print beds are also available, with different tissue culture plates. These are all designed to support applications like cartilage and skin regeneration, or for creating living models for drug development.
Regemat 3D also supplies biomaterials, software, and technical services to support its bioprinting systems.
